Brief: AAP Implantate Expects Significantly Improved EBITDA And In Q3 Of 2020
Oct 9 (Reuters) - AAP IMPLANTATE AG AAQG.DE :
* EXPECTS A SIGNIFICANTLY IMPROVED EBITDA AND RECURRING
EBITDA FOR
Q3 OF 2020.
* SALES IN Q3 OF 2020 WERE THUS ALMOST AT LEVEL OF PREVIOUS
YEAR
AT EUR 2.6 MILLION (Q3/2019: EUR 2.7 MILLION)
* AAP IS AIMING FOR A YEAR-ON-YEAR SALES INCREASE OF AT
LEAST 30%
IN U.S. IN FINANCIAL YEAR 2020 DESPITE COVID-19
Source text for Eikon: ID:nEQ7XvWhKa
Further company coverage: AAQG.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co